NEW YORK — Intercept Pharmaceuticals, Inc. (Intercept), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver diseases, …
Adopted in developing countries; proven technology yet to get recognition in West
The recent Nobel Prize recognition of work on artificially derived multipurpose stem cells by Japanese scientist Shinya Yamanaka is likely to further boost use of the technology in the country's biotech and related industries. It is hoped that his …
SAN DIEGO — Vical Incorporated today reported financial results for the three months and nine months ended September 30, 2012. Revenues were $2.2 million for the third quarter of 2012 compared with $26.6 …
TOKYO and SAN DIEGO, Nov. 6, 2012 /PRNewswire/ — Astellas Pharma Inc. (Tokyo: 4503, Astellas) and Ambit Biosciences Corporation (Ambit) today announced that five oral presentations and three poster presentations …
Optimer's third quarter 2012 net loss of 56 cent per share was narrower the Zacks Consensus loss Estimate of 64 cents
Pfizer and Teva are the largest branded and generic pharmaceutical companies, respectively, as measured by revenue and both reported lower quarterly profits Thursday. The results are connected, due to patent litigation between the companies.
JERSEY CITY, N.J., Nov. 1, 2012 /PRNewswire/ — Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced the Company's financial results for the quarter ended September 30, 2012.(Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO …
In an essay in PLOS Biology , a team from Cold Spring Harbor Laboratory argues that high-throughput DNA sequencing may offer a window into the connections between neurons in the mouse brain.
Pfizer is laying off 300 people from its Canadian workforce , reports The Globe and Mail . That represents about 11 percent of its workers in that country, the paper adds.